CVS Health Corporation
CVS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $102,871 | $98,915 | $94,588 | $97,710 |
| % Growth | 4% | 4.6% | -3.2% | – |
| Cost of Goods Sold | $89,065 | $85,322 | $80,192 | $84,811 |
| Gross Profit | $13,806 | $13,593 | $14,396 | $12,899 |
| % Margin | 13.4% | 13.7% | 15.2% | 13.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $17,013 | $11,212 | $11,022 | $10,531 |
| Operating Expenses | $17,013 | $11,212 | $11,022 | $10,531 |
| Operating Income | -$3,207 | $2,381 | $3,374 | $2,368 |
| % Margin | -3.1% | 2.4% | 3.6% | 2.4% |
| Other Income/Exp. Net | -$275 | -$734 | -$757 | -$242 |
| Pre-Tax Income | -$3,482 | $1,647 | $2,617 | $2,126 |
| Tax Expense | $508 | $634 | $835 | $503 |
| Net Income | -$3,975 | $1,021 | $1,779 | $1,644 |
| % Margin | -3.9% | 1% | 1.9% | 1.7% |
| EPS | -3.13 | 0.81 | 1.41 | 1.31 |
| % Growth | -486.4% | -42.6% | 7.6% | – |
| EPS Diluted | -3.13 | 0.8 | 1.41 | 1.3 |
| Weighted Avg Shares Out | 1,269 | 1,266 | 1,261 | 1,259 |
| Weighted Avg Shares Out Dil | 1,269 | 1,270 | 1,264 | 1,261 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $784 | $763 | $785 | $758 |
| Depreciation & Amortization | $1,134 | $1,171 | $1,154 | $1,147 |
| EBITDA | -$1,564 | $3,581 | $4,556 | $4,027 |
| % Margin | -1.5% | 3.6% | 4.8% | 4.1% |